https://clinicaltrials.gov/ct2/show/NCT03911713?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=03%2F28%2F2019&lupd_d=14
Condition : Cystic Fibrosis
Interventions : Drug: VX-561; Drug: IVA; Drug: Placebo
Sponsor : Vertex Pharmaceuticals Incorporated
Not yet recruiting
A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis
NCT03911713
Thu, 11 Apr 2019 12:00:00 EDT
Last Update Posted: 04/11/19 08:16AM